Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen Utikal
Selma Ugurel

Showing results (291-300 of 490) with videos related to

Pageof 49
Sort By:
Stem Cells (Dayton, Ohio)|January 13, 2016
Directed Dedifferentiation Using Partial Reprogramming Induces Invasive Phenotype in Melanoma CellsNathalie Knappe, Daniel Novak, Kasia Weina, et al.
Frontiers in Immunology|April 3, 2023
COVID-19 vaccination in psoriasis patients receiving systemic treatment: A prospective single-center studyGeorg Christian Lodde, Frederik Krefting, Jan-Malte Placke, et al.
Cancers|April 12, 2022
Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in GermanyPeter Mohr, Emilie Scherrer, Chalid Assaf, et al.
Oncotarget|January 23, 2016
SERPINB1 expression is predictive for sensitivity and outcome of cisplatin-based chemotherapy in melanomaChristoph Willmes, Rajiv Kumar, Jürgen C Becker, et al.
Cancer Immunology, Immunotherapy : CII|December 4, 2020
BRAF and MEK inhibition in melanoma patients enables reprogramming of tumor infiltrating lymphocytesLukas Peiffer, Farnoush Farahpour, Ashwin Sriram, et al.
European Journal of Cancer (Oxford, England : 1990)|November 5, 2013
Upstream mitogen-activated protein kinase (MAPK) pathway inhibition: MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patientsSimone M Goldinger, Lisa Zimmer, Carsten Schulz, et al.
Frontiers in Oncology|September 12, 2022
COVID-19 vaccination in advanced skin cancer patients receiving systemic anticancer treatment: A prospective singlecenter study investigating seroconversion ratesGeorg C Lodde, Melanie Fiedler, Ulf Dittmer, et al.
European Journal of Cancer (Oxford, England : 1990)|August 12, 2019
Impact of American Joint Committee on Cancer 8th edition classification on staging and survival of patients with melanomaTheodora Kanaki, Andreas Stang, Ralf Gutzmer, et al.
Plos One|February 22, 2007
B-RAF and N-RAS mutations are preserved during short time in vitro propagation and differentially impact prognosisSelma Ugurel, Ranjit K Thirumaran, Sandra Bloethner, et al.
Oncogene|December 14, 2020
Merkel cell carcinoma-derived exosome-shuttle miR-375 induces fibroblast polarization by inhibition of RBPJ and p53Kaiji Fan, Ivelina Spassova, Jan Gravemeyer, et al.
Pageof 49

Showing results (291-300 of 490) with videos related to

Sort By:
Pageof 49
Stem Cells (Dayton, Ohio)|January 13, 2016
Directed Dedifferentiation Using Partial Reprogramming Induces Invasive Phenotype in Melanoma CellsNathalie Knappe, Daniel Novak, Kasia Weina, et al.
Frontiers in Immunology|April 3, 2023
COVID-19 vaccination in psoriasis patients receiving systemic treatment: A prospective single-center studyGeorg Christian Lodde, Frederik Krefting, Jan-Malte Placke, et al.
Cancers|April 12, 2022
Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in GermanyPeter Mohr, Emilie Scherrer, Chalid Assaf, et al.
Oncotarget|January 23, 2016
SERPINB1 expression is predictive for sensitivity and outcome of cisplatin-based chemotherapy in melanomaChristoph Willmes, Rajiv Kumar, Jürgen C Becker, et al.
Cancer Immunology, Immunotherapy : CII|December 4, 2020
BRAF and MEK inhibition in melanoma patients enables reprogramming of tumor infiltrating lymphocytesLukas Peiffer, Farnoush Farahpour, Ashwin Sriram, et al.
European Journal of Cancer (Oxford, England : 1990)|November 5, 2013
Upstream mitogen-activated protein kinase (MAPK) pathway inhibition: MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patientsSimone M Goldinger, Lisa Zimmer, Carsten Schulz, et al.
Frontiers in Oncology|September 12, 2022
COVID-19 vaccination in advanced skin cancer patients receiving systemic anticancer treatment: A prospective singlecenter study investigating seroconversion ratesGeorg C Lodde, Melanie Fiedler, Ulf Dittmer, et al.
European Journal of Cancer (Oxford, England : 1990)|August 12, 2019
Impact of American Joint Committee on Cancer 8th edition classification on staging and survival of patients with melanomaTheodora Kanaki, Andreas Stang, Ralf Gutzmer, et al.
Plos One|February 22, 2007
B-RAF and N-RAS mutations are preserved during short time in vitro propagation and differentially impact prognosisSelma Ugurel, Ranjit K Thirumaran, Sandra Bloethner, et al.
Oncogene|December 14, 2020
Merkel cell carcinoma-derived exosome-shuttle miR-375 induces fibroblast polarization by inhibition of RBPJ and p53Kaiji Fan, Ivelina Spassova, Jan Gravemeyer, et al.
Pageof 49